Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor

REFERENCES

• Aggeler, J., Ward, J., Blackie, L. M., Barcellos-Hoff, M. H., Streuli, C. H., and Bissell, M. J.. 1991. Cytodifferentiation of mouse mammary epithelial cells cultured on reconstituted basement membrane reveals striking similarities to development in vivo. J. Cell Sci. 99:407–417
   PubMedGoogle Scholar
• Aronica, S. M., and Katzenellenbogen, B. S.. 1993. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol. Endocrinol. 7:743–752
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff, M. H.. 1992. Mammary epithelial reorganization on extracellular matrix is mediated by cell surface galactosyltransferase. Exp. Cell Res. 201:225–234
   PubMedGoogle Scholar
• Barcellos-Hoff, M. H., Aggeler, J., Ram, T. G., and Bissell, M. J.. 1989. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105:223–235
   PubMed Web of Science ®Google Scholar
• Bartkova, J., Lukas, J., Muller, H., Luzhoft, D., Strauss, M., and Bartek, J.. 1994. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57:353–361
   PubMed Web of Science ®Google Scholar
• Bernards, R.. 1999. CDK-independent activities of D type cyclins. Biochim. Biophys. Acta 1424:M17–M22
   PubMedGoogle Scholar
• Borg, A., Sigurdsson, H., Clark, G. M., Ferno, M., Fuqua, S. A., Olsson, H., Killander, D., and McGuire, W. L.. 1991. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phonotype and poor prognosis. Br. J. Cancer 63:136–142
   PubMed Web of Science ®Google Scholar
• Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K. W., Musgrove, E. A., and Sutherland, R. L.. 1993. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133
   PubMed Web of Science ®Google Scholar
• Chen, D., Pace, P. E., Coombes, C., and Ali, S.. 1999. Phosphorylation of human estrogen receptor α by protein kinase A regulates dimerization. Mol. Cell. Biol. 19:1002–1015
   PubMed Web of Science ®Google Scholar
• Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. A., and Sherr, C. J.. 1999. The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571–1583
   PubMed Web of Science ®Google Scholar
• Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., and Hidaka, H.. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267–5272
   PubMed Web of Science ®Google Scholar
• Cohen, L. A., and Chan, P. C.. 1975. Intracellular cAMP levels in normal rat mammary gland and adenocarcinoma. In vivo vs. in vitro. Life Sci. 16:107–115
   PubMedGoogle Scholar
• Courjal, F., Louason, G., Speiser, P., Katsaros, D., Zeillinger, R., and Theillet, C.. 1996. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int. J. Cancer 69:247–253
   PubMed Web of Science ®Google Scholar
• Daniel, C. W., and Silberstein, G. B.. 1987. Postnatal development of the rodent mammary gland The mammary gland: development, regulation, and function. Neville, M. C., and Daniel, C. W. 3–36 Plenum Press, New York, N.Y
   Google Scholar
• Edwards, P. A.. 1998. Control of the three-dimensional growth pattern of mammary epithelium: role of genes of the Wnt and erbB families studied using recombinant epithelium. Biochem. Soc. Symp. 63:21–34
   PubMedGoogle Scholar
• el-Tanani, M. K., and Green, C. D.. 1996. Interaction between estradiol and cAMP in the regulation of specific gene expression. Mol. Cell. Endocrinol. 29:71–77
   Google Scholar
• Ewen, M. E., Oliver, C. J., Sluss, H. K., Miller, S. J., and Peeper, D. S.. 1995. p53-dependent repression of CDK4 translation in TGF-β-induced G1 cell cycle arrest. Genes Dev. 9:204–217
   PubMed Web of Science ®Google Scholar
• Faraldo, M. M., Deugnier, M.-A., Lukashev, M., Thiery, J. P., and Glukhova, M. A.. 1998. Perturbation of β-integrin function alters the development of murine mammary gland. EMBO J. 17:2139–2147
   PubMedGoogle Scholar
• Fong, J. H., and Ingber, D. E.. 1996. Modulation of adhesion-dependent cAMP signaling by echistatin and alendronate. Biochem. Biophys. Res. Commun. 22:19–24
   Google Scholar
• Forman, B. N., Umesono, K., Chen, J., and Evans, R. M.. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541–550
   PubMed Web of Science ®Google Scholar
• Gardner, R. A., Travers, M. T., Barber, M. C., Miller, W. R., and Clegg, R. A.. 1994. Cyclic AMP-dependent protein kinase in rat mammary tissue: expression of catalytic and regulatory subunits throughout pregnancy and lactation. Biochem. J. 301:807–812
   PubMedGoogle Scholar
• Geng, Y., Whoriskey, W., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., and Sicinski, P.. 1999. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97:767–777
   PubMed Web of Science ®Google Scholar
• Gillet, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G.. 1994. Amplification and overexpression of cyclin D1 in breast cancer detected by immunocytochemical staining. Cancer Res. 54:1812–1817
   PubMed Web of Science ®Google Scholar
• Gillet, C. E., Lee, A. H., Millis, R. R., and Barnes, D. M.. 1998. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperlasia. J. Pathol. 184:396–400
   PubMedGoogle Scholar
• Gordge, P. C., Hulme, M. J., Clegg, R. A., and Miller, W. R.. 1996. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur. J. Cancer 32A:2120–2126
   PubMed Web of Science ®Google Scholar
• Green, H., and Kehinde, O.. 1974. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1:113–116
   Web of Science ®Google Scholar
• Guerinot, F., Delarue, J. C., Contesso, G., and Bohuon, C.. 1977. Adenosine 3′,5′-cyclic monophosphate and guanosine 3′,5′-cyclic monophosphate levels in human breast cancer tissue. Oncology 34:261–263
   PubMedGoogle Scholar
• Hall, M., and Peters, G.. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res. 68:67–108
   PubMed Web of Science ®Google Scholar
• Han, E. K.-H., Begemann, M., Sgambato, A., Soh, J.-W., Doki, Y., Xing, W.-Q., Liu, W., and Weinstein, I. B.. 1996. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ. 7:699–710
   PubMedGoogle Scholar
• Hathaway, H. J., and Shur, B. D.. 1996. Mammary gland morphogenesis is inhibited in transgenic mice that overexpress cell surface beta1,4-galactosyltransferase. Development 122:2859–2872
   PubMedGoogle Scholar
• Henninghausen, L., and Robinson, G. W.. 1998. Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12:449–455
   PubMedGoogle Scholar
• Henry, J. A., Hennessy, C., Levett, D. L., Lennard, T. W., Westley, B. R., and May, F. E.. 1993. int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-myc. Int. J. Cancer 53:774–780
   PubMed Web of Science ®Google Scholar
• Inoue, K., and Sherr, C. J.. 1998. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent kinase-independent mechanism. Mol. Cell. Biol. 18:1590–1600
   PubMed Web of Science ®Google Scholar
• Israeli, E., Raz, B., Kerner, H., and Barzilai, D.. 1985. Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development. Breast Cancer Res. Treat. 6:241–248
   PubMedGoogle Scholar
• Jares, P., Rey, M. J., Fernandez, P. L., Campo, E., Nadal, A., Munoz, M., Mallofre, C., Muntane, J., Nayach, J., Estape, J., and Cardesa, A.. 1997. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. J. Pathol. 182:160–166
   PubMedGoogle Scholar
• Kumar, V., Green, S., Stack, G., Berry, M., Jin, J. R., and Chambon, P.. 1987. Functional domains of the human estrogen receptor. Cell 51:941–951
   PubMed Web of Science ®Google Scholar
• Kung, W., Bechtel, E., Geyer, E., Salokangas, A., Preisz, J., Huber, P., Torhorst, J., Jungmann, R. A., Talmadge, K., and Eppenberger, U.. 1977. Altered levels of cyclic nucleotides, cyclic AMP phosphodiesterase and adenylyl cyclase activities in normal, dysplastic and neoplastic human mammary tissue. FEBS Lett. 82:102–106
   PubMedGoogle Scholar
• LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E.. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847–862
   PubMed Web of Science ®Google Scholar
• Le Goff, P., Montano, M. M., Schodin, D. J., and Katzenellenbogen, B. S.. 1994. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269:4458–4466
   PubMed Web of Science ®Google Scholar
• Levine, J. F., and Stockdale, F. E.. 1985. Cell-cell interactions promote mammary epithelial cell differentiation. J. Cell Biol. 100:1415–1422
   PubMed Web of Science ®Google Scholar
• Loizzi, R. F.. 1983. Cyclic AMP changes in guinea pig mammary gland and milk. Am. J. Physiol. 8: E549
   Google Scholar
• Ma, Z.-Q., Chua, S. S., DeMayo, F. J., and Tsai, S. Y.. 1999. Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B. Oncogene 18:4564–4576
   PubMedGoogle Scholar
• Majumber, G. C.. 1977. Protein kinase activity in mouse mammary carcinoma. Biochem. Biophys. Res. Commun. 74:1140–1145
   PubMedGoogle Scholar
• Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J.-Y.. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076
   PubMed Web of Science ®Google Scholar
• Matsushime, H., Roussel, M. F., Ashmun, R. A., and Sherr, C. J.. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701–713
   PubMed Web of Science ®Google Scholar
• McMahon, C., Suthiphongchai, T., DiRenzo, J., and Ewen, M. E.. 1999. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc. Natl. Acad. Sci. USA 96:5382–5387
   PubMed Web of Science ®Google Scholar
• Meyerson, M., and Harlow, E.. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077–2086
   PubMed Web of Science ®Google Scholar
• Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., and Peterse, J.. 1996. A clinopathological study on overexpression of cyclin D1 and p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer 73:728–734
   PubMed Web of Science ®Google Scholar
• Miller, W. R., Elton, R. A., Dixon, J. M., Chetty, U., and Watson, D. M.. 1990. Cyclic AMP binding proteins and prognosis in breast cancer. Br. J. Cancer 61:263–266
   PubMedGoogle Scholar
• Miller, W. R., Watson, D. M., Jack, W., Chetty, U., and Elton, R. A.. 1993. Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res. Treat. 26:89–94
   PubMedGoogle Scholar
• Minton, J. P., Wisenbaugh, T., and Matthews, R. H.. 1974. Elevated cyclic AMP levels in human breast-cancer tissue. J. Natl. Cancer Inst. 53:283–284
   PubMedGoogle Scholar
• Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., and Ewen, M. E.. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17:5338–5347
   PubMed Web of Science ®Google Scholar
• Norris, J. D., Fan, D., Kerner, S. A., and McDonnell, D. P.. 1997. Identification of a third autonomous activation domain within the human estrogen receptor. Mol. Endocrinol. 11:747–754
   PubMed Web of Science ®Google Scholar
• O'Connor, K. L., Shaw, L. M., and Mercurio, A. M.. 1998. Release of cAMP gating by the α6β4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells. J. Cell Biol. 143:1749–1760
   PubMed Web of Science ®Google Scholar
• Oyama, T., Kashiwabara, K., Yoshimoto, K., Arnold, A., and Koerner, F.. 1998. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res. 58:2876–2880
   PubMed Web of Science ®Google Scholar
• Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J.. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66
   PubMed Web of Science ®Google Scholar
• Prall, O. W. J., Rogan, E. M., Musgrove, E. A., Watts, C. K. W., and Sutherland, R. L.. 1998. c-myc or cyclin D1 mimics estrogen effects on cyclin E-cdk2 activation and cell cycle reentry. Mol. Cell. Biol. 18:4499–4508
   PubMed Web of Science ®Google Scholar
• Rillema, J. A.. 1976. Cyclic nucleotides, adenylate cyclase and cyclic AMP phosphodiesterase in mammary glands from pregnant and lactating mice. Proc. Soc. Exp. Biol. Med. 151: 748
   PubMedGoogle Scholar
• Sakakura, T.. 1991. New aspects of stroma-parenchyma relations in mammary gland differentiation. Int. Rev. Cytol. 125:165–202
   PubMed Web of Science ®Google Scholar
• Sapag-Hagar, M., and Greenbaum, A. L.. 1973. Changes in the activities of adenylate cyclase and cAMP phosphodiesterase and the level of 3′,5′-cyclic adenosine monophosphate in rat mammary gland during pregnancy and lactation. Biochem. Biophys. Res. Commun. 53: 982
   PubMedGoogle Scholar
• Sapag-Hagar, M., and Greenbaum, A. L.. 1974. The role of cyclic nucleotides in the development and function of rat mammary tissue. FEBS Lett. 46: 180
   PubMed Web of Science ®Google Scholar
• Schmeichel, K. L., Weaver, V. M., and Bissell, M. J.. 1998. Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype. J. Mammary Gland Biol. Neoplasia 3:201–213
   PubMedGoogle Scholar
• Schuuring, E., Verhoeven, E., van Tinteren, H., Peterse, J. L., Nunnink, B., Thunninssen, F. B., Devilee, P., Cornelisse, C. J., van de Vijver, M. J., Mooi, W. J., and Michalides, R. J. A. M.. 1992. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 52:5229–5234
   PubMed Web of Science ®Google Scholar
• Sewing, A., and Muller, R.. 1994. Protein kinase A phosphorylates cyclin D1 at three distinct sites within the cyclin box and at the C-terminus. Oncogene 9:2733–2736
   PubMedGoogle Scholar
• Sharoni, Y., Feldman, B., Teuerstein, I., and Levy, J.. 1984. Protein kinase activity in the rat mammary gland during pregnancy, lactation, and weaning: a correlation with growth but not with progesterone receptor levels. Endocrinology 115:1918–1924
   PubMed Web of Science ®Google Scholar
• Sheffield, L. G., Sinha, Y. N., and Welsch, C. W.. 1985. Cholera toxin treatment increases in vivo growth and development of mouse mammary gland. Endocrinology 117:1864–1869
   PubMedGoogle Scholar
• Sherr, C. J.. 1993. Mammalian G1 cyclins. Cell 73:1059–1065
   PubMed Web of Science ®Google Scholar
• Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., and Weinberg, R. A.. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630
   PubMed Web of Science ®Google Scholar
• Silberstein, G. B., Strickland, P., Trumpbour, V., Coleman, S., and Daniel, C. W.. 1984. In vivo, cAMP stimulates growth and morphogenesis of mouse mammary ducts. Proc. Natl. Acad. Sci. USA 81:4950–4954
   PubMedGoogle Scholar
• Sopel, M.. 1995. Electron-microscopic cytochemical localization of adenylate cyclase activity in the myoepithelial cells of the lactating mouse mammary gland. Cell Tissue Res. 279:441–444
   PubMedGoogle Scholar
• Stepanova, L., Leng, X., Parker, S. B., and Harper, J. W.. 1996. Mammalian p50cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes cdk4. Genes Dev. 10:1491–1502
   PubMed Web of Science ®Google Scholar
• Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., and Werb, Z.. 1999. The stromal proteinase MMP3/Stromelysin-1 promotes mammary carcinogenesis. Cell 98:137–146
   PubMed Web of Science ®Google Scholar
• Streuli, C. H., Bailey, N., and Bissell, M. J.. 1991. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J. Cell Biol. 115:1383–1395
   PubMed Web of Science ®Google Scholar
• Streuli, C. H., Schmidhauser, C., Bailey, N., Yurchenco, P., Skubitz, A. P. N., Roskelley, C., and Bissell, M. J.. 1995. Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129:591–603
   PubMed Web of Science ®Google Scholar
• Sweeney, K. J., Swarbrick, A., Sutherland, R. L., and Musgrove, E. A.. 1998. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene 16:2865–2878
   PubMed Web of Science ®Google Scholar
• van den Heuvel, S., and Harlow, E.. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050–2054
   PubMed Web of Science ®Google Scholar
• Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., and Bissell, M. J.. 1997. Reversion of the malignant phenotype of human breast cancer cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137:231–245
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A.. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330
   PubMed Web of Science ®Google Scholar
• Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S.. 1995. Overexpression of cyclin D1 mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med. 1:1257–1260
   PubMed Web of Science ®Google Scholar
• Wiens, D., Park, C. S., and Stockdale, F. E.. 1987. Milk protein expression and ductal morphogenesis in the mammary gland in vitro: Hormone-dependent and -independent phases of adipocyte-mammary epithelial cell interaction. Dev. Biol. 120:245–258
   PubMedGoogle Scholar
• Zwijsen, R. M. L., Buckle, R. S., Hijams, E. M., Loomans, C. J. M., and Bernards, R.. 1998. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev. 12:3488–3498
   PubMed Web of Science ®Google Scholar
• Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R. J. A. M.. 1997. CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405–415
   PubMed Web of Science ®Google Scholar